Expert Interviews

Pharmacotherapy for Myelofibrosis
November 24, 2021

Circumstances for which hydroxyurea, ruxolitinib, or other therapy may be selected to treat newly diagnosed myelofibrosis.

Case 2: Treatment Decisions for a Patient With Chronic GVHD
November 24, 2021

Reactions to a case of chronic graft-vs-host disease and thoughts on sequencing therapy.

Treatment Options for Steroid-Refractory Chronic GVHD
November 24, 2021

The best practices for treating patients with steroid-refractory chronic graft-vs-host disease, with implications for using ruxolitinib based on results of the REACH3 clinical trial.

Increasing Rates of Real-World Studies in EGFR-Mutated NSCLC
November 24, 2021

Drs Lyudmila Bazhenova and Federico Albrecht comment on the significance of real-world data collection in EGFR-mutated non–small cell lung cancer and suggest what can be done to increase the rates of real-world studies conducted.

Stem Cell Transplants in Myelofibrosis
November 24, 2021

Best practices in determining eligibility and preparing patients with myelofibrosis for allogeneic stem cell transplantation.

Role of Conventional Imaging vs PSMA PET in mCNPC
November 24, 2021

A panel of experts in prostate cancer examine the use of conventional imaging and PSMA PET/CT and the impact on their approach to the management of mCNPC.

Patient Case #1: Frontline Therapy for HER2+ mBC
November 23, 2021

Using a patient case to center their discussion, the panel reviews frontline treatment options for HER2+ metastatic breast cancer and the rationale behind selection.

Considerations for HER2+ mBC Management: Biomarkers and Bone Disease
November 23, 2021

Fielding questions from a live audience, experts discuss the lack of biomarkers in HER2+ metastatic breast cancer and how one might address progression of bone disease.

Don Dizon, MD, on Creating a Gender-Affirming Environment for Transgender Patients With Cancer
November 23, 2021

Don Dizon, MD, FACP, FASCO, describes the importance of establishing a gender-affirming environment for patients with cancer.

Hossein Borghaei, DO, MS, Talks Current Research Trends in Lung Cancer
November 21, 2021

CancerNetwork® sat down with Hossein Borghaei, DO, MS, to talk about coming research involving immunotherapy for patients with lung cancer.